Scott Dreyer, EVP & Chief Commercial Officer at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 39,689 shares at $30.03 ($1.2M) on 2025-03-21, disclosed to the SEC on 2025-03-24.
Scheduled sale ($1.2M) by EVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 1,927 | $58K | 4.9% |
| 2 | $30.03 | 18,881 | $567K | 47.6% |
| 3 | $30.03 | 18,881 | $567K | 47.6% |
| Total | $30.03 avg | 39,689 | $1.2M | 100% |
| Filing → |
| COLL | SELL | 2025-08-20 | $1.3M | — | Filing → |
| COLL | SELL | 2025-08-15 | $370K | — | Filing → |
| COLL | SELL | 2025-03-18 | $462K | — | Filing → |